Legal Update

AG recommends narrow interpretation of Neurim in Abraxis

In the on-going case of Abraxis v Comptroller General of Patents, Advocate General (AG) Saugmandsgaard Øe proffered his non-binding opinion at the Court of Justice of the European Union (CJEU) concerning Supplementary Protection Certificates (SPCs) for new formulations of medicinal products.

Legal Update

High time to protect cannabis IP

Aspiring biotech businesses looking to gain a foothold in the fledgling European medical cannabis industry should take a leaf from their Canadian counterparts on intellectual property, say specialist life sciences patent attorneys Micheline Gravelle and Jane Wainwright.

Firm News

Potter Clarkson secures global settlement for Alnylam

Potter Clarkson is delighted to announce that it has secured a global settlement for its client Alnylam Pharmaceuticals, Inc. (Alnylam), the world’s leading RNAi therapeutics company, of worldwide litigation with Silence Therapeutics PLC (Silence).